DUBLIN, May 14, 2019 /PRNewswire/ -- Alkermes plc
(Nasdaq: ALKS) announced today that its Senior Vice President of
Corporate Planning, Blair Jackson,
will participate in a fireside chat at the UBS Global Healthcare
Conference on Monday, May 20, 2019 at
8:00 a.m. ET (1:00 p.m. BST) from New
York. The audio portion of the fireside chat may be accessed
under the Investors tab on www.alkermes.com and will be
archived for 14 days.
Alkermes plc is a fully integrated, global
biopharmaceutical company developing innovative medicines for the
treatment of central nervous system (CNS) diseases. The company has
a diversified commercial product portfolio and a substantial
clinical pipeline of product candidates for chronic diseases that
include schizophrenia, depression, addiction, multiple sclerosis
and oncology. Headquartered in Dublin,
Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and
manufacturing facility in Athlone, Ireland; and a manufacturing facility in
Wilmington, Ohio. For more
information, please visit Alkermes' website
at www.alkermes.com.
Contact:
Alex Braun
Investor Relations
+1 781 296 8493
Logo
- https://mma.prnewswire.com/media/616416/Alkermes_plc_Logo.jpg